Oncology and Pathology, MV
1 – 10 of 2090
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC
- Afadin cooperates with Claudin-2 to promote breast cancer metastasis
- Clinical Application of Fusion Gene Detection Using Next-Generation Sequencing and the NanoString Technology
- Low Postseroconversion CD4+ T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection
- Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
- Written pretest information and germline BRCA1/2 pathogenic variant testing in unselected breast cancer patients : predictors of testing uptake
- Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial
- Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer
- Diagnostic spectrum and time intervals in Sweden's first diagnostic center for patients with nonspecific symptoms of cancer
- Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities : further results from the prospective PANTHER study with focus on obese patients